According to the World Health Organization, there were 39.9 million people living with HIV worldwide by the end of 2023.

VIDEO | Jamtara: On the HIV blood transfusion row involving thalassemia-infected children, Jharkhand Health Minister Irfan ...

Gilead beats estimates, raises 2025 guidance, driven by strong HIV and liver drug sales and multiple launches planned for ...

Rapper Snoop Dogg makes a surprise appearance at Jackson State University for a LGBTQIA+ panel discussion on the HIV/AIDS epidemic.

A man with HIV accused of raping children was arrested by the Memphis Safe Task Force Thursday, the U.S. Marshals Service ...

Gilead is actively looking for late-stage and de-risked assets for potential deals across various therapeutic spaces, ...

People living with HIV who smoke are currently more likely to die from lung cancer than from HIV-related causes. Two cancer ...

For the last several quarters, Gilead Sciences’ earnings calls have been colored by anticipation for the launch of the California drugmaker's long-acting HIV pre-exposure prophylaxis (PrEP) option. | ...

Total product sales -- $7.3 billion in fiscal Q3 2025, up 4% sequentially from Q2 2025, with growth driven by the HIV ...

Gilead stock reversed its early losses Friday as analysts noted encouraging indicators for its newly approved HIV prevention ...

Viral infections trigger inflammation that raises heart disease risk, study finds. Vaccination against COVID, flu and shingles may help prevent cardiovascular complications.

Nearly 40 years after HIV was first identified, the virus continues its devastating march across the globe. Today, 38 million people live with HIV, and each year brings 1.5 million new infections and ...